v3.25.2
FAIR VALUE OF FINANCIAL INSTRUMENTS - Industries and Geographical Locations Comprising Greater than 10% of Portfolio Fair Value (Details) - USD ($)
 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Concentration Risk [Line Items]    
Cost $ 88,404,806 [1] $ 62,547,890 [2]
Fair Value 85,016,596 [3] 59,455,010 [4]
Healthcare & Pharmaceuticals    
Concentration Risk [Line Items]    
Cost 22,729,225 19,518,610
Fair Value $ 22,902,129 $ 19,061,883
Healthcare & Pharmaceuticals | Investments at Fair Value | Industry Concentration Risk    
Concentration Risk [Line Items]    
% of Portfolio 27.00% 32.00%
All Other Industries    
Concentration Risk [Line Items]    
Cost $ 65,675,581 $ 43,029,280
Fair Value $ 62,114,467 $ 40,393,127
All Other Industries | Investments at Fair Value | Industry Concentration Risk    
Concentration Risk [Line Items]    
% of Portfolio 73.00% 68.00%
Total | Investments at Fair Value | Industry Concentration Risk    
Concentration Risk [Line Items]    
% of Portfolio 100.00% 100.00%
[1] See Note 6 for a discussion of the tax cost of the portfolio.
[2] See Note 6 for a discussion of the tax cost of the portfolio.
[3] Fair value is determined by the Company’s Board of Directors (see Note 2).
[4] Fair value is determined by the Company’s Board of Directors (see Note 2).